InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Myers C. Daniel. Director active across 2 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 4 disclosures have been recorded. Activity tracked since 22 June 2023. The latest transaction was filed on 15 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Myers C. Daniel is a declarant and a director of KALA BIO, Inc. and Kala Pharmaceuticals, Inc. The record shows 4 filings, with the sampled filings spanning 2023-06-02 to 2025-06-17, and the sampled filings indicate an attribution transaction nature with buy and sell amounts of EUR 0.